UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review

Therapeutic Advances in Gastroenterology, 2021, Vol.14, p.1756284821993586-1756284821993586

2021

Volltextzugriff (PDF)

Regulation of intestinal permeability: The role of proteases

World journal of gastroenterology : WJG, 2017-03, Vol.23 (12), p.2106-2123

2017

Volltextzugriff (PDF)

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases

World journal of gastroenterology : WJG, 2016-12, Vol.22 (47), p.10275-10286

2016

Volltextzugriff (PDF)

Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis

International journal of molecular sciences, 2021-10, Vol.22 (19), p.10711

2021

Volltextzugriff (PDF)

P2X3 receptors mediate visceral hypersensitivity during acute chemically-induced colitis and in the post-inflammatory phase via different mechanisms of sensitization

PloS one, 2015-04, Vol.10 (4), p.e0123810-e0123810

2015

Volltextzugriff (PDF)

Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer

Microbiome, 2023-04, Vol.11 (1), p.86-86, Article 86

2023

Volltextzugriff (PDF)

The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer Model

Frontiers in pharmacology, 2021-06, Vol.12, p.682065-682065

2021

Volltextzugriff (PDF)

The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult

Frontiers in pharmacology, 2022-06, Vol.13, p.765744-765744

2022

Volltextzugriff (PDF)

Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats

Pharmaceutics, 2021-05, Vol.13 (6), p.811

2021

Volltextzugriff (PDF)

Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study

Frontiers in medicine, 2022-08, Vol.9, p.960000-960000

2022

Volltextzugriff (PDF)

WED-523 - Unraveling the individual contributions of the PPAR isotypes to the pan-PPAR agonist Lanifibranor-induced improvements of the vascular alterations and liver histology in a rat model of early NAFLD

Journal of hepatology, 2023-06, Vol.78, p.S790-S791

2023

Volltextzugriff (PDF)

The pan-PPAR agonist Lanifibranor improves increased portal pressure, endothelial dysfunction and liver histology in a rat model of early NAFLD

Journal of hepatology, 2023-06, Vol.78, p.S776

2023

Volltextzugriff (PDF)

Unraveling the individual contributions of the PPAR isotypes to the pan-PPAR agonist Lanifibranor-induced improvements of the vascular alterations and liver histology in a rat model of early NAFLD

Journal of hepatology, 2023-06, Vol.78, p.S790-S791

2023

Volltextzugriff (PDF)

WED-466 - The pan-PPAR agonist Lanifibranor improves increased portal pressure, endothelial dysfunction and liver histology in a rat model of early NAFLD

Journal of hepatology, 2023-06, Vol.78, p.S776-S776

2023

Volltextzugriff (PDF)

The role of mucins in gastrointestinal barrier function during health and disease

The lancet. Gastroenterology & hepatology, 2022-05, Vol.7 (5), p.455-471

2022

Volltextzugriff (PDF)

394 RESOLVIN D2 REVERSES VISCERAL HYPERSENSITIVITY IN A POSTINFLAMMATORY RAT MODEL FOR IRRITABLE BOWEL SYDNROME

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-71-S-72

2020

Volltextzugriff (PDF)

Mo1571 INTRARECTAL ADMINISTRATION OF A TRPV4 ANTAGONIST IMPROVES POST-INFLAMMATORY VISCERAL HYPERSENSITIVITY IN A RAT MODEL FOR IRRITABLE BOWEL SYNDROME

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-900-S-900

2020

Volltextzugriff (PDF)

Single-day and multi-day exposure to orogastric gavages does not affect intestinal barrier function in mice

American journal of physiology: Gastrointestinal and liver physiology, 2023-04, Vol.324 (4), p.G281-G294

2023

Volltextzugriff (PDF)

Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post‐inflammatory rat model for irritable bowel syndrome

British journal of pharmacology, 2018-09, Vol.175 (17), p.3516-3533

2018

Volltextzugriff (PDF)

103 – Beneficial Effects of a Locally Administered Serine Protease Inhibitor in a Post-Inflammatory Rat Model for Irritable Bowel Syndrome

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-25-S-26

2019

Volltextzugriff (PDF)

1129 - Post-Inflammatory Visceral Hypersensitivity: An Important Role for Serine Proteases and in Particular Tryptase

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S211-S211

2017

Volltextzugriff (PDF)

Mo1597 - Targeting the Serine Protease Pathway in IBS: Beneficial Effects of a Novel small Molecule Inhibitor in Mice

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-765-S-765

2018

Volltextzugriff (PDF)

917 - Butyrate-Producing Synbiotics Reduce Visceral Hyperalgesia and Anxiety-Like Behaviors in a Mouse Model of Irritable Bowel Syndrome, Associated with Inhibition of TRPV1 Currents in Sensory Neurons

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-182-S-182

2018

Volltextzugriff (PDF)

Mas‐related G protein‐coupled receptor C11 (Mrgprc11) induces visceral hypersensitivity in the mouse colon: A novel target in gut nociception?

Neurogastroenterology and motility, 2019-08, Vol.31 (8), p.1-12

2019

Volltextzugriff (PDF)

Post-Inflammatory Visceral Hypersensitivity: An Important Role for Serine Proteases and in Particular Tryptase

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S211-S211

2017

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(9)
Irritable Bowel Syndrome
(9)
Animals
(7)
Colon
(6)
Gastroenterology & Hepatology
(6)
Inflammation
(6)
Immunohistochemistry
(5)
Permeability
(5)
Visceral Hypersensitivity
(5)
Adult
(4)
Audiology & Speech-Language Pathology
(4)
Colitis
(4)
Inflammatory Bowel Disease
(4)
Intestine
(4)
Pain
(4)
Disease Models, Animal
(3)
Distension
(3)
Feces
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review

Regulation of intestinal permeability: The role of proteases

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases

Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis

P2X3 receptors mediate visceral hypersensitivity during acute chemically-induced colitis and in the post-inflammatory phase via different mechanisms of sensitization

Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer

The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer Model

The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult

Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats

Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study

WED-523 - Unraveling the individual contributions of the PPAR isotypes to the pan-PPAR agonist Lanifibranor-induced improvements of the vascular alterations and liver histology in a rat model of early NAFLD

The pan-PPAR agonist Lanifibranor improves increased portal pressure, endothelial dysfunction and liver histology in a rat model of early NAFLD

Unraveling the individual contributions of the PPAR isotypes to the pan-PPAR agonist Lanifibranor-induced improvements of the vascular alterations and liver histology in a rat model of early NAFLD

WED-466 - The pan-PPAR agonist Lanifibranor improves increased portal pressure, endothelial dysfunction and liver histology in a rat model of early NAFLD

The role of mucins in gastrointestinal barrier function during health and disease

394 RESOLVIN D2 REVERSES VISCERAL HYPERSENSITIVITY IN A POSTINFLAMMATORY RAT MODEL FOR IRRITABLE BOWEL SYDNROME

Mo1571 INTRARECTAL ADMINISTRATION OF A TRPV4 ANTAGONIST IMPROVES POST-INFLAMMATORY VISCERAL HYPERSENSITIVITY IN A RAT MODEL FOR IRRITABLE BOWEL SYNDROME

Single-day and multi-day exposure to orogastric gavages does not affect intestinal barrier function in mice

Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post‐inflammatory rat model for irritable bowel syndrome

103 – Beneficial Effects of a Locally Administered Serine Protease Inhibitor in a Post-Inflammatory Rat Model for Irritable Bowel Syndrome

1129 - Post-Inflammatory Visceral Hypersensitivity: An Important Role for Serine Proteases and in Particular Tryptase

Mo1597 - Targeting the Serine Protease Pathway in IBS: Beneficial Effects of a Novel small Molecule Inhibitor in Mice

917 - Butyrate-Producing Synbiotics Reduce Visceral Hyperalgesia and Anxiety-Like Behaviors in a Mouse Model of Irritable Bowel Syndrome, Associated with Inhibition of TRPV1 Currents in Sensory Neurons

Mas‐related G protein‐coupled receptor C11 (Mrgprc11) induces visceral hypersensitivity in the mouse colon: A novel target in gut nociception?

Post-Inflammatory Visceral Hypersensitivity: An Important Role for Serine Proteases and in Particular Tryptase

Suchergebnisse filtern